Valneva has received marketing authorisation from the Brazilian Health Regulator...
Boehringer and Cue Biopharma have entered a strategic research partnership and l...
J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its prof...
In a groundbreaking advancement poised to reshape prognostic assessments in onco...
In a groundbreaking qualitative study published in BMC Cancer, researchers have ...
In the rapidly evolving realm of cancer prognosis, survival analysis stands as a...
A recent groundbreaking study from the Korea Research Institute of Chemical Tech...
Fifty years after its inception, the Endangered Species Act (ESA) stands as a la...
In the relentless pursuit to understand the complex mechanisms driving pancreati...
In the relentless pursuit of advancing cancer diagnostics, researchers have unve...
Cancer continues to pose a formidable challenge to global health, particularly i...
In the realm of modern agriculture, one of the most persistent challenges involv...
A groundbreaking retrospective study from Ankara Oncology Hospital has brought n...
In a groundbreaking randomized controlled trial conducted in the United Arab Emi...
In a groundbreaking move poised to reshape supportive care in hematopoietic stem...
